New Delhi, Feb 15 (UNI) Cadila Healthcare Ltd today introduced 'Nudoxa', an NDDS product used in cancer therapy.
One of the critical drugs used in chemotherapy, Nudoxa promises to be a stable and long lasting drug with reduced toxicity and lesser side effects, a company statement said.
A patented product in India and South Africa, Nudoxa is manufactured by Zydus-BSV Pharma Pvt Ltd, the joint venture company of Zydus Cadila and Bharat Serums and Vaccines Pvt Ltd, and marketed by Zydus Biogen.
The drug is a new variant of liposomal doxorubiein and prevents from major side effects of the cancer therapy like 'Hand-Foot Syndrome', characterised by skin eruptions on the palms of hands or soles of feet.
The medicine is being used as a chemotherapy drug to treat various cancers, particularly breast cancer, ovarian cancer and HIV infections.
UNI SG PDT RAI1254